Fig. 11From: Isolation, characterization, therapeutic potency, and genomic analysis of a novel bacteriophage vB_KshKPC-M against carbapenemase-producing Klebsiella pneumoniae strains (CRKP) isolated from Ventilator-associated pneumoniae (VAP) infection of COVID-19 patientsMeasuring the optical absorbance of CRKP strain, Kp100 treated with different MOIs of phage vB_KshKPC-M at a wavelength of 570Â nm during 24Â h of incubationBack to article page